GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmunityBio Inc (STU:26CA) » Definitions » Net Interest Income (for Banks)

ImmunityBio (STU:26CA) Net Interest Income (for Banks)


View and export this data going back to 2021. Start your Free Trial

What is ImmunityBio Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


ImmunityBio (STU:26CA) Business Description

Industry
Traded in Other Exchanges
Address
3530 John Hopkins Court, San Diego, CA, USA, 92121
ImmunityBio Inc is a late-clinical-stage immunotherapy company developing next-generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. Geographically, the company operates in United States and Europe. Majority of the revenue is generated from Europe.